The laboratory services company has agreed to purchase certain assets of Incyte's clinical and anatomic pathology testing ...

Sequel is a U.S. based specialty pharma company with expertise in developing and commercializing niche drugs. It has ...

An under-the-radar court ruling may be among the most significant harbingers of the crises to come for the FDA and public ...

In chronic lymphocytic leukemia (CLL), certain recurrent genetic alterations are known to influence disease progression and ...